Aclaris Therapeutics, Inc. · NASDAQ:ACRS

The Vanguard Group's stake in Aclaris Therapeutics, Inc. fell below 5% (Schedule 13G/A)

Event Mar 13, 2026 · Filed Mar 26, 2026

The Vanguard Group's stake in Aclaris Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).

Stake
0%
Shares
0
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
The Vanguard Group0%0

Source

View original at SEC

Related